A randomised phase II trial of 177Lu-PSMA617 theranostic versus cabazitaxel in progressive metastic castration resistant prostate cancer (ANZUP1603). TheraP Study

Project: Research

Project Description

NMA HREC Ref number: HREC 17/PMCC/85
NMA SSA Ref number: SSA/18/MonH/39
SEO code - 920102 Cancer and Related Disorders
StatusActive
Effective start/end date6/02/185/02/23